VIDEO: Stelara can safely be used long-term to benefit patients with UC, Crohn’s

In a Healio video exclusive, Remo Panaccione, MD, discusses results from long-term, pooled analyses of adult patients treated with ustekinumab for inflammatory bowel disease.“We know that Stelara (ustekinumab, Janssen) is a highly effective therapy in inflammatory bowel disease when it’s either used first-line or in patients who have been exposed to other advanced therapies,” Panaccione, professor of medicine and director of the Inflammatory Bowel Disease Clinic at the University of Calgary, said. “This data really gives us the confidence that, in addition to its ability toRead More

Related Articles